Where BoomRx sits in the pharmacy stack
Compounded and manufactured medications for cash-pay clinics flow through a specific stack: the prescriber writes the order, a procurement platform routes it, a licensed pharmacy makes or sources it, and a carrier ships it to the patient. BoomRx occupies the procurement-platform layer. It does not compound medications and does not hold a pharmacy license — its 503A and 503B partners do that work.
This distinction matters when you evaluate BoomRx. Questions about compounding quality, certificates of analysis, and state licensure are ultimately about the pharmacy partners behind the platform, not the software. Questions about pricing visibility, patient-linked checkout, and per-line audit are about the platform itself — and that is where BoomRx and alternatives like Fizy Health diverge.